| Patents for A61K 45 - Medicinal preparations containing active ingredients not provided for in groups (115,020) |
|---|
| 09/12/2002 | CA2439666A1 Nitrogen-containing heteroaryl compounds having hiv integrase inhibitory activity |
| 09/12/2002 | CA2439594A1 Interleukin-8 homologous polypeptides and therapeutic uses thereof |
| 09/12/2002 | CA2439581A1 Use of gabaa inverse agonists in combination with nicotine receptor partial agonists, estrogen, selective estrogen modulators, or vitamin e for the treatment of cognitive disorders |
| 09/12/2002 | CA2439504A1 Compositions and methods relating to osteoarthritis |
| 09/12/2002 | CA2439293A1 Enteral formulation |
| 09/12/2002 | CA2439205A1 Nuclear hormone receptor ligand binding domain |
| 09/12/2002 | CA2439203A1 Nuclear hormone receptor ligand binding domain |
| 09/12/2002 | CA2439200A1 Nuclear hormone receptor ligand binding domain |
| 09/12/2002 | CA2439197A1 Nuclear hormone receptor ligand binding domain |
| 09/12/2002 | CA2439196A1 Nuclear hormone receptor ligand binding domains |
| 09/12/2002 | CA2439195A1 Nuclear hormone receptor ligand binding domain |
| 09/12/2002 | CA2439192A1 Nuclear hormone receptor ligand binding domain |
| 09/12/2002 | CA2438849A1 Compounds and compositions for delivering active agents |
| 09/12/2002 | CA2438326A1 Compositions and methods for enhancing drug delivery across and into epithelial tissues |
| 09/12/2002 | CA2434601A1 Methods for specifically inhibiting histone deacetylase-4 |
| 09/12/2002 | CA2434066A1 Chromane derivatives, process for their preparation and their use as antitumor agents |
| 09/12/2002 | CA2433933A1 Use of lp82 to treat hematopoietic disorders |
| 09/12/2002 | CA2432280A1 Novel glutamate receptor modulatory proteins and nucleic acid molecules and uses therefor |
| 09/12/2002 | CA2431549A1 Substituted 8-arylquinoline phosphodiesterase-4 inhibitors |
| 09/11/2002 | EP1239033A1 Semaphorin receptor |
| 09/11/2002 | EP1238676A1 Combination of a serotonin reuptake inhibitor and an atypical antipsychotic for use in depression, obsessive compulsive disorder and psychosis |
| 09/11/2002 | EP1238670A1 Composition and method for treating and preventing cardiovascular disease and hypertension. |
| 09/11/2002 | EP1238666A2 Use of xanthenone-4-acetic acid in the manufacture of a medicament in the treatment of hyperproliferative disorders |
| 09/11/2002 | EP1238660A1 Sustained delivery of an active agent using an implantable system |
| 09/11/2002 | EP1238659A1 Sustained delivery of an active agent using an implantable system |
| 09/11/2002 | EP1238658A1 Sustained delivery of an active agent using an implantable system |
| 09/11/2002 | EP1238657A1 Sustained delivery of an active agent using an implantable system |
| 09/11/2002 | EP1238656A1 Sustained delivery of an active agent using an implantable system |
| 09/11/2002 | EP1238282A2 Methods of diagnosis and treatment by binding p75/airm1 |
| 09/11/2002 | EP1238281A2 Cancer associated antigens and uses therefor |
| 09/11/2002 | EP1238098A2 Plasminogen activator assay involving an elastase inhibitor |
| 09/11/2002 | EP1238080A2 Bcl-g polypeptides, encoding nucleic acids and methods of use |
| 09/11/2002 | EP1238077A1 Tnfr/opg-like molecules and uses thereof |
| 09/11/2002 | EP1238072A2 Compositions and methods for inhibiting human immunodeficiency virus infection by down-regulating human cellular genes |
| 09/11/2002 | EP1238070A2 Therapeutically useful synthetic oligonucleotides |
| 09/11/2002 | EP1238066A2 Masp-3, a complement-fixing enzyme, and uses for it |
| 09/11/2002 | EP1238063A2 Tankyrase h, compositions involved in the cell cycle and methods of use |
| 09/11/2002 | EP1237925A1 MUTANT ER$g(a) AND TEST SYSTEMS FOR TRANSACTIVATION |
| 09/11/2002 | EP1237917A2 Protein c derivatives |
| 09/11/2002 | EP1237915A2 Polynucleotid encoding the rg1 polypeptide |
| 09/11/2002 | EP1237914A1 Methods for improving secondary metabolite production in fungi |
| 09/11/2002 | EP1237891A1 Heterocyclic dihydropyrimidines as potassium channel inhibitors |
| 09/11/2002 | EP1237880A2 Pyrazine based inhibitors of glycogen synthase kinase 3 |
| 09/11/2002 | EP1237845A1 Aminobenzophenones as inhibitors of il-1beta and tnf-alpha |
| 09/11/2002 | EP1237698A2 Water unstable foam compositions |
| 09/11/2002 | EP1237577A2 Transmucosal composition containing a phosphodiesterase inhibitor for the treatment of erectile dysfunction |
| 09/11/2002 | EP1237576A1 Antiviral agent for use in treatment of cancer |
| 09/11/2002 | EP1237575A1 Tnf-alpha antagonist and lfa-1 antagonist for treating lfa-1 or tnf-alpha mediated disorder |
| 09/11/2002 | EP1237569A1 An additive for an animal feed |
| 09/11/2002 | EP1237568A1 A conjugate of a collagen ii-binding fragment and an arthritis-affecting pharmaceutical substance |
| 09/11/2002 | EP1237559A1 Pharmaceutical combinations |
| 09/11/2002 | EP1237558A1 Novel helicobacter pylori-binding substances and use thereof |
| 09/11/2002 | EP1237554A2 Use of sodium channel antagonists for the treatment of diseases related to apoptosis |
| 09/11/2002 | EP1237553A2 The combination of a serotonin reuptake inhibitor and a 5-ht 2c? antagonist, inverse agonist or partial agonist |
| 09/11/2002 | EP1237546A2 Dihydroorotate dehydrogenase inhibitors for the treatment of viral-mediated diseases |
| 09/11/2002 | EP1237543A1 Effervescent histamine h2 antagonist composition |
| 09/11/2002 | EP1207908A4 Method of treating body insect infestation |
| 09/11/2002 | EP1133500B1 Organophosphorous compounds and the use thereof |
| 09/11/2002 | EP0944715B1 Pressure-mediated intracellular delivery of molecules or microparticles |
| 09/11/2002 | EP0917427B1 Teat dipping agent |
| 09/11/2002 | EP0880363B1 Combinations, having immunosuppressive effects, containing a cyclooxygenase-2 inhibitor and a leukotriene a 4 hydrolase inhibitor |
| 09/11/2002 | EP0840603B1 Pharmaceutical composition of l-dopa ethyl ester |
| 09/11/2002 | CN1369015A Recombinant anti-CD 40 antibody and uses thereof |
| 09/11/2002 | CN1368957A Aminobenzophenones as inhibiotors of IL-1 beta and TNF-alpha |
| 09/11/2002 | CN1368953A Aminobenzophenones as inhibitors of IL-1 bata and TNF-alpha |
| 09/11/2002 | CN1368950A Novel aminobenzophenones |
| 09/11/2002 | CN1368881A Use of inhibitors of renin-angiotensin systemin prevention of cardiovascular events |
| 09/11/2002 | CN1368879A Use of (-)(3-trihalomethylphenoxy) (4-halophenyl) acetic acid derivatives for treatment of insulin resistance type 2 diabetes, hyperlipidemia and hyperuricemia |
| 09/11/2002 | CN1368878A Drug therapy of restless leg syndrome |
| 09/11/2002 | CN1368874A Implantable active ingredient depot |
| 09/11/2002 | CN1090481C Estrogen/progestion-antiprogestin application its composition and medicine box |
| 09/11/2002 | CN1090479C Combination of a cholesteral biosynthesis inhibitor and a beta-lactam cholesterol absorption inhibitor |
| 09/10/2002 | US6448468 Transgenetic mouse which comprises an inactive Peg3 gene, and the use thereof |
| 09/10/2002 | US6448429 Protein tyrosine phosphatase 1B (PTP-1B) inhibitors containing two ortho-substituted aromatic phosphonates |
| 09/10/2002 | US6448378 Made by preparing a purified solution of monoreactive-amine modified collagen, such as glutaric anhydride derivatized collagen, heating to reduce viscosity and adding the drug to the solution, casting into thin layers, drying into film |
| 09/10/2002 | US6448276 Such as 1-pyridin-3-yl-4-pyrrolidin-1-yl-but-1-ene; increasing hydration and lubrication of vaginal and cervical tissues; nicotine, epibatidine alkaloids and analogs |
| 09/10/2002 | US6448264 Use of 5-thio-, sulfinyl- and sulfonylpyrazolo[3,4-b]-pyridines as cyclin dependent kinase inhibitors |
| 09/10/2002 | US6448258 Heterocyclic amine compounds |
| 09/10/2002 | US6448245 Methods of and compounds for inhibiting calpains |
| 09/10/2002 | US6448235 Agonists of a2a adenosine receptors in combination with rolipram, its derivatives or other type iv phosphodiesterase (pde) inhibitor are effective for the treatment of inflammatory diseases |
| 09/10/2002 | US6448233 System for dispensing benzoyl peroxide and macrolide or aminoglycoside antibiotic for treatment of acne wherein each is present in a high concentration and dispensing causes mixing to achieve desired concentration for topical use |
| 09/10/2002 | US6448231 Presynaptic neurotoxin such as botulinum toxin a |
| 09/10/2002 | US6448223 Antagonists of HMG1 for treating inflammatory conditions |
| 09/10/2002 | US6448221 By administering an adipocyte complement related protein to reduce platelet aggregation |
| 09/10/2002 | US6448037 PgsA |
| 09/10/2002 | US6448032 With anti-inflammatory and antipyretic function and involved in a number of diseases such as melanoma and skin cancer |
| 09/10/2002 | US6448019 Inhibit vascular smooth muscle cell activation and/or proliferation or enhance vascular endothelial cell activation and/or proliferation or activate estrogen responsive genes in vascular cells. vasoprotective agents are vasospecific, |
| 09/10/2002 | US6448011 Isolated nucleic acid, vectors, transformed mammalian cells and non-human transgenic animals that encode and express normal or mutant adrenergic receptor genes. |
| 09/10/2002 | US6448006 Methods and compositions for reducing bacterial tolerance to antibacterials disinfectants and organic solvents |
| 09/10/2002 | US6448000 Viral growth and cellular genes that function as tumor suppressors. thus, the present invention provides nucleic acids related to and methods of reducing or preventing viral infection or cancer. the invention also provides methods of |
| 09/10/2002 | US6447809 Composition for promoting healthy bone structure |
| 09/10/2002 | US6447787 Methods for enhancing wound healing |
| 09/10/2002 | US6447785 Method for treating hypercalcemia |
| 09/10/2002 | US6447783 Compositions comprising FGF9 and use thereof for stimulating cartilage and bone repair |
| 09/10/2002 | US6447763 Method and system for production and collection of lavage induced stool (LIS) for chemical and biologic tests of cells |
| 09/10/2002 | US6447754 Aqueous ingestible solution of calcium glycerophosphate |
| 09/10/2002 | US6447750 Medicinal aerosol formulation |
| 09/10/2002 | CA2288375C Novel pulmonary surfactants and therapeutic uses, including pulmonary lavage |
| 09/06/2002 | WO2002068677A2 Novel methods of diagnosis of metastatic colorectal cancer, compositions and methods of screening for modulators of metastatic colorectal cancer |
| 09/06/2002 | WO2002068654A2 Recombinant poxvirus for chimeric proteins of the human immunodeficiency virus |